Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alzer + Diamel
- Development stage
- Unknown
- Lead developer
- Laboratorios Catalysis
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Alzer + Diamel is a combination of two nutritional supplements developed by Catalysis S.L. for the management of diabetic complications, specifically diabetic macular edema (DME). Alzer is an antioxidant-rich supplement containing ingredients such as Ginkgo biloba, alpha-lipoic acid, and vitamins, which are intended to reduce oxidative stress and provide neuroprotection to the retina. Diamel is a metabolic regulator containing amino acids (like arginine and glycine), vitamins, and minerals (such as zinc and magnesium) designed to improve glycemic control and insulin sensitivity. The combination therapy aims to provide a synergistic effect by addressing both the metabolic dysregulation and the resulting oxidative damage associated with diabetes. It has been evaluated in Phase II clinical trials for its efficacy in treating mild to moderate macular edema.
- Other names
- Alzer + Diamel
02
Targets
INSR (Insulin receptor)
Beyond the preview
Go deeper on Alzer + Diamel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alzer + Diamel.